Home / About PPME / News
News
Problematic patent settlements in EU on the decrease
2011-11-22 The European Commission’s (EC) second monitoring exercise of patent settlements in the pharmaceutical sector has shown a continuing decline of potentially problemati...
Read more
Biosimilar substitution in the EU
2011-11-18 Although many things—including regulations for licensing of biosimilars—are harmonised within the EU, the attitude towards biosimilars and their substitution within...
Read more
Boehringer Ingelheim joins other Big Pharma going into biosimilars
2011-11-17 Big Pharma is once again taking a major interest in biosimilars. The latest big pharmaceutical player to show an interest is biopharmaceutical specialist Boehringer...
Read more
EC to investigate patent settlements again
2011-11-16 The European Commission (EC) has once again requested information from pharmaceutical companies regarding patent settlement agreements concluded in the European Econ...
Read more
Medicines pricing policies in Europe: a review
2011-11-15 The OECD countries spent 4.6% more per capita per year on pharmaceuticals from 1995 to 2005 although the annual average economic growth was only 2.2% during the same...
Read more
EMA biosimilar regulation should include complex biologicals
2011-10-17 The EMA’s comprehensive biosimilar regulatory pathway, which includes the need for new clinical trials and comparability studies that demonstrate quality, efficacy,...
Read more
EMA comparability studies limiting biosimilar success
2011-10-14 The EMA’s comprehensive biosimilar regulatory pathway, which includes the need for new clinical trials and comparability studies that demonstrate quality, efficacy,...
Read more
Actavis launches generic olanzapine in 11 European markets
2011-10-13 Eli Lilly is facing yet more pressure as generics makers queue up to produce copies of its blockbuster antipsychotic drug Zyprexa (olanzapine). On 30 September 2011,...
Read more
Hospira looks to biosimilars and increased use of generics for growth
2011-10-12 Injectable generics leader, Hospira, announced on 7 September 2011 at its investor day, that it will look to biosimilars and international expansion for future growt...
Read more
Sanofi France to make generic atorvastatin
2011-10-11 The French daily newspaper, Les Echos, reported on 1 September 2011 that sanofi France (sanofi) had reached an agreement with Pfizer to produce generic versions of t...
Read more
European Commission publishes new rules on falsified medicines
2011-09-15 A new directive on falsified medicines was published in the Official Journal of the European Union 1 July 2011.This legislation is the outcome of the legal proposal...
Read more
Doctors wary of using biosimilars for extrapolated indications
2011-09-15 A report published on 24 August 2011 by research and advisory firm Decision Resources finds that the majority of US and European physicians are wary of using a biosi...
Read more
Last update: 2008-09-06 | 
Go Back | 
Print View
